Christopher J. Lindop, CFO & EVP Business Development at HAEMONETICS CORP (HAE), sold 4,902 shares at $38.49 ($189K) on 2015-08-20, disclosed to the SEC on 2015-08-24.
Scheduled sale ($189k) by CFO & EVP Business Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| HAE | SELL | 2015-07-21 | $192K | — | Filing → |
| HAE | SELL | 2015-06-23 | $208K | — | Filing → |
| HAE | SELL | 2015-05-21 | $204K | — | Filing → |